An update from CSL ( (AU:CSL) ) is now available.
CSL Limited has updated its previous announcement regarding the dividend distribution for its ordinary fully paid shares. The update includes details on currency rates and local currency conversions for the dividend related to the six-month period ending December 31, 2024. This announcement is significant for stakeholders as it provides clarity on the financial aspects of the dividend distribution, potentially impacting investor decisions and market perceptions.
More about CSL
CSL Limited operates in the biotechnology industry, focusing on the development and delivery of innovative medicines and vaccines. The company is known for its work in the areas of immunology, hematology, and vaccines, serving a global market with a strong emphasis on research and development.
YTD Price Performance: -5.98%
Average Trading Volume: 866
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $76.74B
See more insights into CSL stock on TipRanks’ Stock Analysis page.